Literature DB >> 32679280

Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic.

Raveena Khanna1, Christina D Kwon2, Sagar P Patel2, Micah Belzberg2, Kyle A Williams2, Ramona Khanna2, Emily Boozalis3, Shawn G Kwatra4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32679280     DOI： 10.1016/j.jaad.2020.07.017

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  [Neuropathic pruritus-Evidence-based treatment recommendations].

Authors:  Panoraia Baka; Frank Birklein
Journal:  Nervenarzt       Date:  2022-08-11       Impact factor: 1.297

2.  Evaluating the Effectiveness of Intranasal Butorphanol in Reducing Chronic Itch.

Authors:  Angelina Labib; Teresa Ju; Zoe Morgan Lipman; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2022-06-09       Impact factor: 3.875

Review 3.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

4.  Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.

Authors:  Sarina Elmariah; Sarah Chisolm; Thomas Sciascia; Shawn G Kwatra
Journal:  JAAD Int       Date:  2022-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.